Steven D. Rhodes, Ph.D.
Affiliations: | 2013 | Anatomy & Cell Biology | Indiana University, Bloomington, Bloomington, IN, United States |
Area:
Cell Biology, Biomechanics Biophysics, Molecular Biology, Evolution and Development BiologyGoogle:
"Steven Rhodes"Parents
Sign in to add mentor| Feng-Chun Yang | grad student | 2013 | Indiana University | |
| (Dissecting the cellular and molecular mechanisms mediating neurofibromatosis type 1 related bone defects.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Flint AC, Mitchell DK, Angus SP, et al. (2023) Combined CDK4/6 and ERK1/2 inhibition enhances anti-tumor activity in NF1-associated plexiform neurofibroma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Staedtke V, Topilko P, Le LQ, et al. (2023) Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas. The Journal of Investigative Dermatology |
| Cumpston EC, Rhodes SD, Yates CW. (2023) Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas. Current Oncology Reports |
| Mund JA, Park S, Smith AE, et al. (2020) Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 17. The Journal of Biological Chemistry. 295: 9948-9958 |
| Ma Y, Gross AM, Dombi E, et al. (2020) A molecular basis for neurofibroma-associated skeletal manifestations in NF1. Genetics in Medicine : Official Journal of the American College of Medical Genetics |
| Mund JA, Park SJ, Smith AE, et al. (2020) Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1. The Journal of Biological Chemistry |
| Armstrong AE, Rhodes SD, Smith A, et al. (2020) Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1. Pediatric Blood & Cancer. e28372 |
| Burks CA, Rhodes SD, Bessler WK, et al. (2019) Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1-Deficient Mice. Molecular Cancer Therapeutics |
| Rhodes SD, He Y, Smith A, et al. (2019) Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation. Human Molecular Genetics |
| Gehlhausen JR, Hawley E, Wahle BM, et al. (2018) A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas. Human Molecular Genetics |